Purpose: Recently, substrate-based catheter ablation (CA) can be applied to more complicated cases. We aimed to compare the effi cacy between substratebased and activation/entrainment-based VT ablation. Methods: We investigated consecutive 76 patients (55 male) with structural heart disease who underwent CA of VT to analyze relationship between ablation-strategy and clinical outcome. The patients included 25 individuals with ARVC, 16 with ischemic heart disease, 14 with DCM, 11 with sarcoidosis, and 10 with other heart diseases. The patients were divided into two groups according to ablation-strategy, substrate-based mapping group (Group-S, N=45) and activation/entrainment mapping group (Group-AE, N=31). Successful CA was defi ned as non-inducibility of any VT at the end of procedure. Results: There were no signifi cant differences in LVEF, and percentage of ICD implantation between 2 groups. There were also no signifi cant differences in percentage of successful CA and number of RF applications. During 4 years of follow-up, no signifi cant differences were shown in recurrences of sustained VT, hospitalization due to heart failure, and cardiac death.
